David Epstein is a seasoned executive with extensive experience in leadership roles across various companies. Currently serving as Chairman and CEO of Ottimo Pharma, Chairman of Agomab, and Board Member at Tempus AI, PELICAN HARBOR SEABIRD STATION INC, and Valo, Epstein also holds the position of Managing General Partner at Remedii LLC, providing consulting and board services. Notably, Epstein was Chief Executive Officer at Seagen during a successful acquisition, and has served as an Independent Director at Cellestia Biotech and Woolsey Pharma. Epstein earned an MBA in Finance and Marketing from Columbia Business School and a BS in Pharmacy from Rutgers University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices